Affibody signs distribution agreement with Funakoshi
Advertisement
Affibody AB and Funakoshi Co., Ltd., announced an agreement in which Funakoshi will promote and distribute products from Affibody's portfolio of biotechnology research reagents to the Japanese market.
"We are delighted with this distribution agreement, Affibody's exciting new class of affinity ligands complement our range of top quality products and will enable us to meet the high demand for research reagents in Japan" said Dr. Ryoya Funakoshi, President & CEO of Funakoshi Co., Ltd. Torben Jørgensen, CEO of Affibody, added: "Funakoshi has an excellent reputation on the Japanese market and we appreciate that Funakoshi Co., Ltd. operates as our distributor as it opens up an important sales channel for Affibody. We look forward to a fruitful and long-lasting cooperation".
Most read news
Other news from the department business & finance
These products might interest you
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.